ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester

carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester

carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester Structure
CAS No.
929693-30-1
Chemical Name:
carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester
Synonyms
Edoxaban-20;Yidu Saban Impurity O;Edoxaban Hydroxy t-BOC Impurity;Edoxaban Impurity 17 (1R,2R,5S);N,N'-Bis-(5-chloro-pyridin-2-yl)-oxalamide;CARBAMICACID,N-((1R,2R,5S)-((DIMETEYLAMINO)CARBONYL)-2-HYDRO;CARBAMICACID,N-((1R,2R,5S)-((DIMETEYLAMINO)CARBONYL)-2-HYDRO 1G;(1S,3R,4R)-3-(Boc-amino)-4-hydroxy-N,N-dimethylcyclohexanecarboxamide;tert-Butyl ((1R,2R,5S)-5-(dimethylcarbamoyl)-2-hydroxycyclohexyl)carbamate;tert-butyl N-[(1R,2R,5S)-5-(dimethylcarbamoyl)-2-hydroxycyclohexyl]carbamate
CBNumber:
CB23032840
Molecular Formula:
C14H26N2O4
Molecular Weight:
286.37
MOL File:
929693-30-1.mol
MSDS File:
SDS
Modify Date:
2022/8/26 12:20:28

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H315-H319
Precautionary statements  P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester Chemical Properties,Uses,Production

carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester Preparation Products And Raw materials

carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester Spectrum

carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester tert-Butyl ((1R,2R,5S)-5-(dimethylcarbamoyl)-2-hydroxycyclohexyl)carbamate tert-butyl N-[(1R,2R,5S)-5-(dimethylcarbamoyl)-2-hydroxycyclohexyl]carbamate CARBAMICACID,N-((1R,2R,5S)-((DIMETEYLAMINO)CARBONYL)-2-HYDRO 1G CARBAMICACID,N-((1R,2R,5S)-((DIMETEYLAMINO)CARBONYL)-2-HYDRO Tert-butyl {(1R,2R,5S)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexylcarbonyl}carbamate Edoxaban impurity 15/tert-Butyl ((1R,2R,5S)-5-(dimethylcarbamoyl)-2-hydroxycyclohexyl)carbamate Edoxaban-20 [(1R,2R,5S)-5-(dimethylcarbamoyl)-2-hydroxycyclohexyl]carbamic acid tert-butyl ester Edoxaban Hydroxy t-BOC Impurity carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl es (1S,3R,4R)-3-(Boc-amino)-4-hydroxy-N,N-dimethylcyclohexanecarboxamide Edoxaban Impurity 17 (1R,2R,5S) Yidu Saban Impurity O N,N'-Bis-(5-chloro-pyridin-2-yl)-oxalamide 929693-30-1